The United States Pharmacopeia Accepts Amgen's Aranesp for Treatment of Chemotherapy-Associated Anemia Read more about The United States Pharmacopeia Accepts Amgen's Aranesp for Treatment of Chemotherapy-Associated Anemia
UPDATE: FDA Approves Amgen's Neulasta for Serious and Frequent Chemotherapy Side Effect Read more about UPDATE: FDA Approves Amgen's Neulasta for Serious and Frequent Chemotherapy Side Effect
Multimedia Available: FDA Approves Amgen's Neulasta for Serious & Frequent Chemotherapy Side Effect Read more about Multimedia Available: FDA Approves Amgen's Neulasta for Serious & Frequent Chemotherapy Side Effect
FDA Approves Amgen's Neulasta for Serious and Frequent Chemotherapy Side Effect Read more about FDA Approves Amgen's Neulasta for Serious and Frequent Chemotherapy Side Effect
Amgen and Immunex Receive Request for Additional Information From The Federal Trade Commission Read more about Amgen and Immunex Receive Request for Additional Information From The Federal Trade Commission
Amgen's First Research and Development Day Highlighted 24 of the Approximately 40 Programs in its Pipeline Read more about Amgen's First Research and Development Day Highlighted 24 of the Approximately 40 Programs in its Pipeline
Amgen Announces Award for Science Teaching Excellence in Puerto Rico Read more about Amgen Announces Award for Science Teaching Excellence in Puerto Rico
Amgen Announces Award for Science Teaching Excellence Read more about Amgen Announces Award for Science Teaching Excellence
Amgen Announces Award for Science Teaching Excellence Read more about Amgen Announces Award for Science Teaching Excellence
Frank Herringer Nominated for Amgen Board of Directors Read more about Frank Herringer Nominated for Amgen Board of Directors
